Login / Signup

Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.

Shuwei ZhouSiyu WangJian XiangZhongyu HanWeilang WangShuhang ZhangNoble Chibuike OparaShenghong JuYing CuiYuan-Cheng Wang
Published in: Abdominal radiology (New York) (2024)
ECA-MRI exhibited overall comparable diagnostic performance to EOB-MRI in assessing residual or recurrent HCC after LRT.
Keyphrases
  • contrast enhanced
  • magnetic resonance imaging
  • diffusion weighted imaging
  • magnetic resonance
  • computed tomography
  • combination therapy